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4-Hydroxy-2-nonenal induces 
apoptosis by activating ERK1/2 
signaling and depleting intracellular 
glutathione in intestinal epithelial 
cells
Yun Ji1, Zhaolai Dai1, Guoyao Wu1,2 & Zhenlong Wu1
Excessive reactive oxygen species (ROS) induces oxidative damage to cellular constituents, ultimately 
leading to induction of apoptotic cell death and the pathogenesis of various diseases. The molecular 
mechanisms for the action of ROS in intestinal diseases remain poorly defined. Here, we reported 
that 4-hydroxy-2-nonenal (4-HNE) treatment led to capses-3-dependent apoptosis accompanied 
by increased intracellular ROS level and reduced glutathione concentration in intestinal epithelial 
cells. These effects of 4-HNE were markedly abolished by the antioxidant L-cysteine derivative 
N-acetylcysteine (NAC). Further studies demonstrated that the protective effect of NAC was associated 
with restoration of intracellular redox state by Nrf2-related regulation of expression of genes involved 
in intracellular glutathione (GSH) biosynthesis and inactivation of 4-HNE-induced phosphorylation 
of extracellular signal-regulated protein kinases (ERK1/2). The 4-HNE-induced ERK1/2 activation 
was mediated by repressing mitogen-activated protein kinase phosphatase-1 (MKP-1), a negative 
regulator of ERK1/2, through a proteasome-dependent degradation mechanism. Importantly, either 
overexpression of MKP-1 or NAC treatment blocked 4-HNE-induced MKP-1 degradation, thereby 
protecting cell from apoptosis. These novel findings provide new insights into a functional role of MKP-1 
in oxidative stress-induced cell death by regulating ERK1/2 MAP kinase in intestinal epithelial cells.
Excessive generation of reactive oxygen species (ROS) and/or defective antioxidant activity contributes to cellular 
redox imbalance, which is a critical pathogenic factor associated with various diseases1,2. Intestinal epithelium is 
constantly exposed to reactive oxygen metabolites from luminal contents or systemic oxidants which are rapidly 
removed by anti-oxidant systems, and a defect in this pathway leads to reversible or irreversible cellular injury3. 
Persistently elevated ROS triggers genetic or epigenetic alterations, resulting in oxidative damage to cell con-
stituents (e.g. proteins, lipids, and nucleic acids), ultimately leading to induction of apoptotic cell death and the 
pathogenesis of various gastrointestinal disorders including peptic ulcers, gastrointestinal cancers, and inflam-
matory bowel disease1,4,5. In addition, several lines of studies show that enteral commensal or probiotic bacteria 
in the lumen of small intestine affect diverse homeostatic functions, including regulation of cellular growth, 
maintenance of barrier function, and modulation of immune responses by targeting the intestinal redox-oxidant 
balance6,7, suggesting a critical role of redox in intestinal epithelial survival and homeostasis3.
4-Hydoxy-2-nonenal (4-HNE) is originally identified as an end product formed by the reaction of ROS with 
polyunsaturated fatty acids during oxidative stress8,9. Growing evidence indicates that 4-HNE can function as 
an important second messenger and, therefore, has been implicated in the regulation of various cellular pro-
cesses, including cell proliferation, differentiation, apoptosis, inflammatory response and endoplasmic reticulum 
stress8,10–12. A number of signaling proteins involved in cell proliferation or apoptotic cell death signaling path-
ways, such as p5313, protein kinase B (also known as AKT)14,15, and mitogen-activated protein (MAP) kinases16,17 
are regulated by 4-HNE and contribute to cell proliferation or cell death in multiple types of cells. As one of the 
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main cell types that constitute the intestinal barrier, intestinal epithelium forms a single layer and separates the 
intestinal luminal contents from the internal environment, ensuring the absorption of nutrients and irons and 
also preventing the passage of harmful or unwanted substances from entering the circulation. The proper func-
tion of the intestinal barrier is maintained by the well-controlled balance between cell proliferation and apoptosis 
in which ROS may play a regulatory role18. First, intestinal epithelium has a highly metabolic rate with a rapid 
turnover within 3–4 days, compared with other organs, which confers to the ROS generation in the milieus19. 
Second, intestinal epithelial cells are constantly exposed to antigens, toxins, and commensal or pathogenic bac-
teria, which can activate cellular defense or detoxification system accompanied by elevated ROS production19,20. 
All these findings indicate that the intestine is highly susceptible to the damaging effect of ROS and its metabolite, 
including 4-HNE.
It has been reported that 4-HNE induces apoptotic cell death by regulating the expression of proteins 
involved in cell death signaling pathways21, as well as proteins implicated in stressor (such as H2O2, UV, heat, 
and oxidant chemicals) -triggered apoptosis12. Despite the new knowledge of 4-HNE in the regulation of var-
ious cellular processes, the cellular response to 4-HNE and underlying apoptotic mechanisms in normal intes-
tinal epithelium remains unknown. In this study, we reported that incubation of intestinal epithelial cells with 
4-HNE led to caspase 3-dependent apoptosis, which was abolished by the antioxidant L-cysteine derivative, 
N-acetylcysteine (NAC). The protective effect of NAC was associated with restoration of redox state and inactiva-
tion of 4-HNE-induced extracellular signal-regulated protein kinases ERK1/2 phosphorylation through repress-
ing mitogen-activated protein kinase phosphatase-1 (MKP-1).
Results
NAC attenuated 4-HNE-induced cell death in intestinal epithelial cells. To assess the cytotoxic 
effect of 4-HNE and a potential role of antioxidant on 4-HNE- induced oxidative stress, normal small intestinal 
epithelial cells (IEC-6 and IPEC-1) pretreated with or without NAC (5 mM, 2 h) were exposed to 4-HNE for 
indicated time points. As shown in Fig. 1A, 4-HNE treatment led to decreased viability of both IEC-6 and IPEC-1 
cells in a dose-dependent manner (Fig. 1A). However, the reduced cell viability observed upon 4-HNE treat-
ment was markedly attenuated by NAC treatment in both cell lines (Fig. 1A). Morphological observation using 
phase contrast microscopy demonstrated that 4-HNE treatment resulted in a significant increase of floating cells, 
appearance of cell shrinkage and boundary contraction as compared with control cells in both cell lines, which 
were markedly reversed by NAC treatment (Fig. 1B). This morphological alteration was confirmed by Hoechst 
33342 and propidium iodide (PI) staining (Fig. 1C,D), suggesting a protective effect of NAC on 4-HNE induced 
cell death in intestinal epithelial cells.
The protective effect of NAC on 4-HNE-induced cell death was associated with inactivation 
of caspase 3-dependent apoptosis. To investigate the characteristic of cell death as observed, NAC-pretreated 
cells were incubated with or without 4-HNE and then were collected for apoptosis assays, including FACS 
and Western blot analysis. As shown, 4-HNE single treatment resulted in marked cell death as indicated by an 
increased number of apoptotic cells (Fig. 2A,B) which were mostly abolished by the NAC. In agreement with 
observed phenotype, 4-HNE treatment resulted in the accumulation of cleaved caspase-3 and PARP, two char-
acteristics of apoptosis, in both the dose- (Fig. 2C) and time-dependent manner (Fig. 2D). Notably, the effects of 
4-HNE were largely abolished by NAC (Fig. 2C,D). In contrast, NAC single treatment did not induce apoptosis 
as evidenced by FACS analysis and Western blot analysis in both cell lines. Importantly, inhibition of caspase 3 
by Ac-DEVD-CHO protected cells from 4-HNE-induced apoptosis (Fig. 2E). These results indicated that 4-HNE 
exposure triggered caspase 3-dependent apoptosis in intestinal epithelial cells which can be abrogated by an 
antioxidant NAC.
Nrf2-related restoration of intracellular redox states contributed to the protective effect of 
NAC on 4-HNE-induced apoptosis. As NAC is a potent antioxidant22, we next explored the intracellular 
ROS production in intestinal epithelial cells treated with 4-HNE, NAC, or NAC and 4-HNE co-treatment. As 
demonstrated, 4-HNE treatment led to increased ROS levels as evidenced by the DCFH-DA assay, which were 
significantly alleviated by NAC (Fig. 3A). Similarly, the concentration of intracellular GSH, the main redox mol-
ecule, decreased following 4-HNE treatment, which was markedly reversed by NAC in both IEC-6 and IPEC-1 
cells (Fig. 3B). Considering that the nuclear factor erythroid 2–related factor 2 (Nrf2) is a critical regulator for 
cellular response to antioxidant defense23, we next examined the effect of 4-HNE, NAC, or 4-HNE + NAC on 
nucleus and cytoplasmic content of Nrf2 protein. As showed, 4-HNE or NAC treatment has modest effect on Nrf2 
(Fig. 4A) in both cell lines. In contrast, 4-HNE and NAC co-treatment increased Nrf2 protein in nuclear frac-
tions (Fig. 4A). Consistently, the mRNA expression of GCLC, the catalytic subunit of GCL (glutamate-cysteine 
ligase, also known as γ -glutamylcysteine synthetase (γ -GCS), and glutathione synthetase (GSS), two essential 
enzymes for the synthesis of glutathione24,25) were significantly upregulated by 4-HNE and NAC combination 
treatment at 4–6 h post-treatment compared with that of 4-HNE single treatment in both IEC-6 and IPEC-1 
cells (Fig. 4B). Additionally, the mRNA levels for Nrf2 downstream targets, including HO1 (heme oxygenase 1), 
NQO1 (NAD(P)H:quinone oxidoreductase 1), and GSTA4 (glutathione S-transferase alpha 4) (Fig. 4C) were 
markedly up-regulated in 4-HNE and NAC co-treated cells compared with cells treated with 4-HNE alone. All 
these data indicated that 4-HNE-induced cell apoptosis was associated with GSH depletion and downregulation 
of Nrf2 related antioxidant redox signaling. Accordingly, exogenous NAC abolished 4-HNE-induced cell death 
by an Nrf2-related increase in expression of genes involved in GSH biosynthesis and antioxidant response in 
intestinal epithelial cells.
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Modulating of ERK1/2 activation was responsible for the apoptotic effect induced by 
4-HNE. Mitogen-activated protein kinases (MAPK), including extracellular signal–regulated kinase1/2 
(ERK1/2), c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK), and p38 MAP kinase are well 
known kinases involved in the regulation of apoptosis and cell survival in response to various stresses, including 
ROS26,27. We next determined protein expression profiles using Western blot in both IEC-6 and IPEC-1 cells 
treated with 4-HNE, NAC or 4-HNE in combination with NAC treatment. 4-HNE exposure led to elevated lev-
els of protein phosphorylation, including ERK1/2, JNK and p38 MAP kinases in IPEC-1 cells which are mostly 
attenuated by NAC (Fig. 5A). In contrast, 4-HNE treatment resulted in activation of ERK1/2 without affecting 
the phosphorylation of JNK and p38 MAP kinases in IEC-6 cells (Fig. 5B). The inactivation of ERK1/2 phos-
phorylation by NAC in 4-HNE-treated cells were further confirmed in the time course experiment involving 
both IEC-6 and IPEC-1 cells (Fig. 5B), suggesting that ERK1/2 activation might be responsible for the cell death 
effects caused by 4-HNE in intestinal epithelial cells. To further demonstrated the functional role of ERK1/2 
activation in 4-HNE-induced apoptotic effects, cells pretreated with or without U0126, a specific inhibitor of 
the ERK1/228, were incubated in the presence or absence of 4-HNE. Our results indicated that ERK1/2 inhibitor 
U0126 abrogated 4-HNE-induced ERK1/2 phosphorylation (Fig. 5C) and cell death (Fig. 5D) in both IEC-6 and 
IPEC-1 cells. In contrast, 4-HNE-induced cell death was not rescued by SB203580, a p38 inhibitor, or SP600125, 
a JNK inhibitor in IPEC-1 cells (Data not shown). These data indicated that ERK1/2, instead of p38 MAPK 
Figure 1. NAC attenuated 4-HNE-induced cell death in intestinal epithelial cells. (A) Cells were pre-
incubated in serum-free medium with or without NAC (5 mM) for 2 h and then were exposed to various 
concentrations of 4-HNE as indicated for an additional 8 h. Cell viability was evaluated using the cell counting 
kit-8 (CCK-8) reagent, n = 6. *p < 0.01 compared with the control, #p < 0.01 compared with 4-HNE alone.  
(B) Morphological observations of IEC-6 and IPEC-1 cells exposed to 4-HNE (80 μ M for IEC-6 and 40 μ M for 
IPEC-1, respectively) in the presence or absence of NAC (5 mM) for pretreatment. (C) Hoechst 33342 and PI 
staining of cells. Cells were treated as in Fig. 1B and then were stained with Hoechst 33342 (5 μ g/ml) and PI 
(2.5 μ g/ml), magnification x 100. (D) Statistical analysis for Hoechst 33342/PI double positive cells treated as in 
Fig. 1C. Cell numbers were counted from three independent micrographs for each treatment, *p < 0.01.
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or JNK, is responsible for 4-HNE-mediated apoptosis in intestinal epithelial cells. Antioxidant NAC prevented 
4-HNE-induced ERK1/2 activation, thereby exerting an anti-apoptotic effect.
PERK-eIF2α signaling was not involved in 4-HNE-induced ERK1/2 activation. P53 plays an 
important role for cell fate decision in response to oxidative stress29. Activation of p53 has been reported to 
contribute to 4-HNE-induced cell death by inducing downstream pro-apoptotic proteins including MAP 
kinases13. However, 4-HNE treatment failed to activate p53 and downstream target such as Bax and BCL-XL/S 
(Supplementary Figure S1A), and appeared not to be a regulator of ERK1/2 activation in our study. Recent 
study shows that ERK1/2 can be activated by PERK-eIF2α signaling in response to ROS and involved in 
caspase-dependent apoptosis30. As expected, 4-HNE treatment led to a markedly increase in the phosphoryl-
ation of eIF2α , which was largely abolished by NAC in both IEC-6 and IPEC-1 cells (Fig. 6A). To determine 
a potential regulatory relationship between eIF2α and ERK1/2, epithelial cells pretreated with a PERK inhibi-
tor GSK260641431, were exposed to 4-HNE. Western blot analysis revealed that PERK inhibitor GSK2606414 
Figure 2. The protective effect of NAC on 4-HNE-induced cell death was associated with inactivation of 
caspase-3-dependent apoptosis. (A) Cells pretreated with or without NAC (5 mM) in serum-free medium for 2 h 
and then were exposed to 4-HNE (80 μ M for IEC-6 and 40 μ M for IPEC-1, respectively) for an additional 8 h. Cell 
apoptosis was evaluated using the Annexin-V/PI double staining kit by flow cytometry. (B) Statistical analysis 
for Annexin-V positive cells treated as in Fig. 2A. Values are expressed as the mean ± SEM (n = 3), *p < 0.01. 
(C) Immunoblotting analysis of pro-caspase-3, cleaved caspase-3 and PARP in cells treated with indicated 
concentrations of 4-HNE for 8 h in the presence or absence of NAC pretreatment (5 mM). (D) Immunoblotting 
analysis for pro-caspase-3, cleaved caspase-3 and PARP in cells treated with 4-HNE (80 μ M for IEC-6 and 40 μ 
M for IPEC-1, respectively) with or without NAC pretreatment for indicated time periods; β -actin was used as a 
loading control. (E) Caspase-3 inhibitor Ac-DEVD-CHO protected cells from 4-HNE-induced apoptosis. Cells 
pretreated with Ac-DEVD-CHO (50 μ M) for 1 h were treated with 4-HNE (80 μ M for IEC-6 and 40 μ M for IPEC-1, 
respectively) for 8 h and and cell apoptosis was determined by Hoechst 33342/PI double staining. Values are 
expressed as the mean ± SEM (n = 3), *p < 0.01.
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blocked 4-HNE-induced eIF2α activation, but had no effect on the protein level of ERK1/2 (Fig. 6B). Collectively, 
these results indicated that 4-HNE enhanced PERK-eIF2α signaling as previously reported32, but this signaling 
did not contribute to ERK1/2 activation in intestinal epithelial cells.
MKP-1 was a critical regulator modulating ERK1/2 activation in response to oxidant exposure. 
As the activity of ERK1/2 is tightly regulated by the coordinated action of several protein phosphatases, we next 
investigated the possible involvement of protein phosphatases that responsible for the activation of ERK1/2 in 
intestinal epithelial cells. As shown, 4-HNE treatment led to down-regulation of the protein level of MKP-1, a 
main phosphatase that inactivates MAP kinases, without affecting the protein level of PP2A, in both IEC-6 and 
IPEC-1 cells (Fig. 7A). Importantly, NAC incubation reversed 4-HNE-induced decrease in MKP-1 protein level, 
indicating a potentially regulatory relationship between MKP-1 and ERK1/2 activation in epithelial cells. To 
explore whether this effect of 4-HNE on MKP-1 occurred at the transcriptional level, epithelial cells were treated 
with either 4-HNE or 4-HNE and NAC at different time points. Real-time PCR results showed that 4-HNE treat-
ment led to a markedly increase in MKP-1 mRNA levels as earlier as 2 h post-treatment in both IEC-6 and IPEC-1 
cells, and the values were further enhanced by NAC (Fig. 7B), thus excluding the possibility of regulation at the 
transcriptional level. Of interest, ERK1/2 phosphorylation and the MKP-1 down-regulation following 4-HNE 
treatment were reversed by a proteasome inhibitor MG132 (Fig. 7C, upper panel). Consistent with the changes in 
protein levels, 4-HNE-induced cell death was significantly abolished by MG132 (Fig. 7C, lower panel), indicating 
a post-translational regulation of MKP-1 in 4-HNE treated cells. To validate the repressing effect of MKP-1 on 
ERK1/2 activation, HEK293 cells transfected with empty vector or wild type MKP-1 vector were subjected to 4-HNE 
or left untreated. Overexpression of wild type MKP-1 significantly inhibited ERK1/2 phosphorylation in the presence 
of 4-HNE, and did not affect the abundance of total ERK1/2 protein (Fig. 7D). To confirm the anti-apoptotic effects 
of MKP-1 in epithelial cells, IEC-6 cells stably expressing wild type MKP-1 were selected and subjected to 4-HNE 
treatment. The introduction of wild type MKP-1 significantly attenuated 4-HNE-induced ERK1/2 activation and 
cytotoxicity (Fig. 7E). These results strongly suggested that repressing MKP-1 was critical for 4-HNE-induced ERK1/2 
activation and cell death in intestinal epithelial cells. It is noteworthy that NAC abrogated 4-HNE-induced ERK1/2 
activation by inhibiting MKP-1 degradation, thus improving cell survival in response to 4-HNE treatment (Fig. 7F).
Figure 3. The restoration of intracellular redox states contributed to protective effect of NAC on 4-HNE-
induced apoptosis. (A) ROS production triggered by 4-HNE was blocked by NAC pretreatment. Cells 
pretreated with or without NAC (5 mM, 2 h) in serum-free medium were loaded with the DCFH-DA probe 
(10 μ M) and then were treated 4-HNE (80 μ M for IEC-6 and 40 μ M for IPEC-1) for 2 h, the fluorescence was 
measured immediately using a fluorescence microscope. (magnification x 100) (B) The intracellular GSH levels 
in epithelial cells. Cells pretreated with or without NAC (5 mM, 2 h) were treated with 4-HNE (80 μ M for IEC-6 
and 40 μ M for IPEC-1) for 6 h. The intracellular GSH levels were determined by high performance liquid 
chromatography (HPLC). Values are expressed as the mean ± SEM (n = 3), *p < 0.01.
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Discussion
ROS has been implicated in the pathogenesis of a variety of intestinal disorders, such as peptic ulcers, gastro-
intestinal cancers, and inflammatory bowel disease, due to its high metabolic rate and constantly exposure to 
luminal contents (e.g., toxin, commensal bacteria, and other factors) that contribute to ROS generation within 
the gastrointestinal tract2,5. Although aberrant regulation of redox homeostasis and oxidative stress in cancer cells 
has been well-studied, their roles in normal intestinal epithelium and gastrointestinal diseases remain unknown. 
Therefore, understanding the signaling pathways of ROS-related cell death would provide important clues to the 
mechanisms responsible for intestinal epithelial cell injury and the development of intestinal disease.
In the present study, we showed that 4-HNE, a major end product of lipid peroxidation and a widely accepted 
inducer of oxidative stress9,33, induced ROS- related cell death in both IEC-6 and IPEC-1, two widely used intes-
tinal epithelial cells, as revealed by double staining assays, Facs, and immunoblot analysis. Of note, apoptosis 
of these cells was markedly reduced by NAC, a potent antioxidant. Although ROS has been reported to induce 
cell cycle arrest in several types of mammalian cell34, little is known about this effect in intestinal epithelial 
cells. However, both the cell cycle profiles and the protein levels of p21 and p27 (Data not shown), two inhib-
itory CDK regulators associated with cell cycle arrest, were not affected by 4-HNE treatment. Importantly, the 
Figure 4. Nrf2-related signaling was activated by NAC pretreatment in 4-HNE-treated cells. (A) Cytoplasmic 
and nucleus protein levels for Nrf2. Cells pre-treated with or without NAC (5 mM) for 2 h were treated with 
4-HNE for 2 h. Cytoplasmic and nuclear fractions were extracted and the protein levels for Nrf2 were analyzed 
by Western blot. GAPDH and Histone H3 were used as loading controls for the fraction of cytoplasmic or 
nucleus protein, respectively. (B) mRNA levels for GCLC and GSS in intestinal epithelial cells. Cells pre-treated 
with or without NAC (5 mM, 2 h) were treated with 4-HNE (80 μ M for IEC-6 and 40 μ M for IPEC-1) for 
indicated time points, qRT-PCR was performed to determine the mRNA expression level for GCLC and GSS. β -actin 
was used as the reference control. Values are expressed as the mean ± SEM (n  =  3), *p < 0.01 compared with 
that of 0 h control of the same treatment, #p < 0.01 compared with that of 4-HNE treatment without NAC pre-
incubation at the same time points. (C) mRNA levels for HO1, NQO1 and GSTA4 in intestinal epithelial cells. 
Cells were treated as in Fig. 3C and qRT-PCR was performed to determine the mRNA levels for indicated genes, 
β -actin was used as the reference control. Values are expressed as the mean ± SEM (n = 3), *p < 0.01 compare 
with that of 0 h control of the same treatment, #p < 0.01 compared with that of 4-HNE exposure without NAC 
pretreatment at the same time point.
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pro-apoptotic effect of 4-HNE was associated with intracellular GSH depletion and activation of extracellular 
signal-regulated protein kinases ERK1/2 activation. Blockage of ERK1/2 activation by pharmacological inhib-
itor abrogated 4-HNE induced cell death, implicating ERK1/2 as a critical factor that responsible for the cell 
death effect (Fig. 7F). Accumulating data points to an essential role for ROS in the activation of autophagy35. 
However, the protein level of LC3, a marker of autophagy, was not affected by 4-HNE, NAC, or 4-HNE and NAC 
co-treatment (Supplementation Fig S1B), thus excluding the involvement of autophagic cell death triggered by 
4-HNE in our study.
GSH is essential for cell survival as depletion of intracellular GSH results in massive apoptotic cell death in 
multiple cell lines36 or knock-out mice37. Conversely, overexpression of γ -GCS, a rate-limiting enzyme for GSH 
synthesis, has been shown to protect against apoptosis induced by stimuli that activate cell death pathways38. 
Despite much progress on 4-HNE-triggered apoptosis in cancer cells, there is very limited data in normal intes-
tinal epithelial cells, especially considering that 4-HNE can accumulate up to concentrations of 10 μ mol/L to 
5 mmol/L9,33. In the present study, we found that 4-HNE exposure led to decreased GSH level and altered cellular 
redox state which is in agreement with previous studies9.
Figure 5. Modulating of ERK1/2 activation was responsible for the apoptotic effect induced by 4-HNE.  
(A) Western blot analysis of MAP kinase expression in intestinal epithelial cells. Cells pretreated with NAC 
(5 mM, 2 h) were exposed to 4-HNE (80 μ M for IEC-6 and 40 μ M for IPEC-1) for 8 h, the protein levels of ERK1/2, 
p-ERK1/2, p38 MAPK, p-p38 MAPK, JNK and p-JNK were determined using indicated antibodies. β -actin was 
used as the loading control. (B) Western blot analysis of ERK1/2 activation in a time dependent manner. Cells 
pretreated with NAC (5 mM, 2 h) were exposed to 4-HNE for different time periods. The protein levels of ERK1/2, 
and p-ERK1/2 were determined. β -actin was used as the loading control. (C) Western blot analysis of ERK1/2 
activation in intestinal epithelial cells treated with 4-HNE in the presence or absence of U0126. Cells pretreated 
with U0126 (10 μ M, 1 h) were treated with indicated concentrations of 4-HNE for 2 h. The protein levels of ERK1/2, 
and p-ERK1/2 were determined. β -actin was used as the loading control. (D) Inhibition of ERK1/2 activation 
blocked 4-HNE-induced cell apoptosis. Cells were treated with 4-HNE (80 μ M for IEC-6 and 40 μ M for IPEC-1) 
for 8h after U0126 pretreatment (10 μ M, 1 h), and then cell apoptosis was determined by Facs analysis. Values are 
expressed as the mean ± SEM (n = 3), *p < 0.01.
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Nrf2 has also been shown to protect against oxidative stress-induced cell death by regulating enzymes involved 
in GSH biosynthesis as well as genes implicated in antioxidative defense39–42. Induction of antioxidant enzymes by 
activation of Nrf2 signaling has been considered as a promising strategy to combat with oxidative stress-related 
diseases23. In our study, we found 4-HNE treatment did not activate Nrf2 which is not in agreement with previous 
studies showing accumulation of nuclear Nrf2 upon oxidative stress43,44. One of the reasons for this discrepancy 
might due to a higher concentration of 4-HNE was used in our study compared with previous ones. In our pilot 
study, we found 2–5 μ M 4-HNE induced cell proliferation (data not shown), in contrast, a higher concentration 
of 4-HNE induced cell death as shown herein and its underlying mechanisms. It has been also reported that low 
concentrations of 4-HNE induces adaptive response by activating Nrf2 signaling, while higher concentrations of 
4-HNE impair Nrf2 nuclear accumulation and result in apoptosis45. Interestingly, NAC markedly up-regulated 
the mRNA level of enzymes (GCLC and GSS) involved in GSH synthesis, boosted Nrf2-related detoxifying 
capability by transcriptionally up-regulating expression of HO-1 and NQO1, phase 2 enzymes that participates 
in the scavenging of ROS46,47, and promoted the production of GSTA4 to remove intracellular 4-HNE (Fig. 4), 
thus restoring the redox and protecting intestinal epithelial cells from 4-HNE induce cell damage as previously 
reported48,49.
Mitogen-activated protein kinases (MAPKs), including the c-JunNH2-terminal kinases (JNK1⁄2), the p38 
MAP kinases, and extracellular signal-regulated kinase (ERK1/2) signaling pathways, are well known to be 
activated in response to the intracellular redox state and oxidative stress, and potentially contribute to influ-
encing cell survival or cell death50,51. To evaluate the functional role of MAP kinase signallings responsible for 
4-HNE-induced apoptosis, we determined the activation of MAP kinases by Western blot analysis. As shown, 
ERK1/2, instead of p38 MAP kinase or JNK1/2, phosphorylation was markedly induced by 4-HNE in both IEC-6 
and IPEC-1 cells, indicating a potential involvement of ERK1/2 in response to ROS insults in intestinal epithelial 
cells. Important, 4-HNE-induced ERK1/2 activation and cell death was markedly abolished by ERK1/2 inhibitor 
U0126 (Fig. 5), suggesting a critical role for ERK1/2 activation on cell death. This result is in agreement with 
data from renal epithelial cells52, alveolar epithelium53, or human proximal tubular epithelial cells54. Although 
the p5313 and PERK-eIF2α pathways30 have been reported to regulate ERK1/2 activation in response to various 
stresses, including 4-HNE, and contribute to cell death, this was not the observed in intestinal epithelial cells. In 
contrast, we found that activation of ERK1/2 following 4-HNE treatment was mediated by repressing MKP-1, a 
negative regulator of MAP kinases55. Such a regulatory relationship was further supported by ectopic expression 
Figure 6. PERK-eIF2α signaling was not involved in 4-HNE induced ERK1/2 activation. (A) 4-HNE-
induced eIF2α activation was inhibited by NAC pretreatment. Cells pretreated with NAC (5 mM, 2 h) were 
exposed to 4-HNE as indicated for 2 h, the protein levels of eIF2α and p-eIF2α were determined using indicated 
antibodies. β -actin was used as the loading control. (B) PERK inhibitor had no effect on 4-HNE-induced 
ERK1/2 activation. Cells pretreated with or without the GSK2606414 (10 μ M, 1 h) were treated with 4-HNE as 
indicated for additional 1 h. The protein levels of ERK1/2 and p-ERK1/2 were determined in IEC-6 (left panel) 
and IPEC-1 cells (right panel).
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experiments in both HEK293 and IEC-6 cells. Importantly, cells stably expressed wild type MKP-1 was resistant to 
4-HNE induced ERK1/2 activation and cell death as compared with control cells (Fig. 7), indicating an anti-apoptotic 
effect of MKP-1 in response to oxidative stress. Additionally, our results also indicated that ERK1/2 was a preferred 
substrate repressed by MKP-1. First, ERK1/2 was markedly induced by 4-HNE which was accompanied by MKP-1 
degradation in both IEC-6 and IPEC-1 cells (Fig. 7A), whereas the activation of p38 and JNK was modestly induced 
in IPEC-1 cells. Second, protein degradation inhibitor MG132 reversed ERK1/2 activation by abolishing MKP-1 
down-regulation. Third, ectopic expression of wild type MKP-1 blocked 4-HNE-induced ERK1/2 phosphorylation 
Figure 7. MKP-1 was a critical regulator modulating ERK1/2 activation following exposure to oxidant.  
(A) NAC prevented 4-HNE-induced MKP-1 down-regulation. Cells pretreated with NAC (5 mM, 2 h) were 
exposed to 4-HNE, the protein levels of MKP-1 and PP2A were determined using indicated anti-bodies. β -actin 
was used as the loading control. (B) Relative mRNA levels of MKP-1 in intestinal epithelial cells. IEC-6 (left panel) 
or IPEC-1 (right panel) cells pretreated with or without NAC were treated with 4-HNE, qRT-PCR was performed 
to determine the mRNA levels of MKP-1. β -actin was used as the reference control. Values are mean ± SEM (n = 3), 
*p < 0.01 compare with that of 0 h control of the same treatment. 4-HNE treatment control, #p < 0.01 compared 
with that of 4-HNE alone at the same time point. (C) Protein degradation inhibitor blocked 4-HNE-induced 
MKP-1 down-regulation, ERK1/2 phosphorylation and apoptosis. IEC-6 cells were left untreated or treated with 
4-HNE in the presence or absence of a proteolysis inhibitor MG132 (1 μ M). The protein levels of MKP-1, ERK1/2, 
and p-ERK1/2 were determined. β -actin was used as the loading control. Cell apoptosis was evaluated by Hoechst 
33342/PI staining. Values are expressed as mean ± SEM (n = 3), *p < 0.01. (D) MKP-1 repressed 4-HNE-induced 
ERK1/2 activation. HEK293 cells transfected with empty vector or MKP-1 vector were treated with 4-HNE for 2 h. 
The protein levels of MKP-1, ERK1/2, and p-ERK1/2 were determined. β -actin was used as the loading control. 
(E) Overexpression of MKP-1 abolished 4-HNE-induced ERK1/2 activation and cell death. IEC-6 cells transfected 
with empty vector or MKP-1 vector were treated with 4-HNE. The protein level of MKP-1, ERK1/2, and p-ERK1/2 
(upper panel) and cell viability (lower panel) were determined. Values are mean ± SEM, *p < 0.01. (E) Proposed 
mechanism responsible for 4-HNE-induced apoptosis in intestinal epithelial cells.
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and cell death but did not affect the protein levels of phosphorylated JNK and p38 MAPK (data not shown). Further 
studies are required to elucidate the underlying mechanisms responsible for this substrate preference.
In conclusion, 4-HNE exposure resulted in a caspase-3-dependent apoptosis in intestinal epithelial cells. This 
effect was associated with decreased intracellular GSH levels and activation of ERK1/2, which can be reversed by a 
potent antioxidant NAC. Mechanistically, the activation of ERK1/2 was mediated by proteasome-dependent pro-
tein degradation of MKP-1, a negative regulator of ERK1/2. NAC treatment restored intracellular redox states by 
Nrf2-related up-regulation of enzymes involved in GSH biosynthesis and genes involved in anti-oxidative defense, 
as well as inhibition of 4-HNE-induced MKP-1 degradation, thereby protecting cells from 4-HNE-induced apop-
tosis. The results from this study established a novel pathway that involves superoxide production, MKP-1 degra-
dation and ERK1/2 activation in response to oxidative stress. Our results also support a role of NAC as a potential 
powerful antioxidant for prevention or therapy of intestinal disease caused by oxidative stress.
Materials and Methods
Reagents. 4-Hydoxy-2-nonenal was bought from Cayman Chemical Co. (Ann Arbor, MI). N-Acetylcysteine 
was purchased from Sigma Chemical Co. (St. Louis, MO). DMEM/F12, DMEM and fetal bovine serum (FBS) 
were obtained from GIBCO BRL (Grand Island, NY). DCFH-DA was purchased from Beyotime Institute of 
Biotechnology (Haimen, China). Antibodies against PARP, MKP-1, Nrf2, p53, Bax, Bcl-xL/S, GAPDH, his-
tone H3 and β -actin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies against 
caspase-3, cleaved-caspase-3, total and phospho (p)-ERK1/2 (Thr202/Tyr204), JNK, p-JNK, p38 MAPK, p-p38 
MAPK, eIF2α , p-eIF2α (Ser51), LC3A/B and PP2A were products of Cell Signaling Technology (Beverly, 
MA). Peroxidase-conjugated goat anti-rabbit and goat anti-mouse secondary antibodies were purchased from 
Huaxingbio Biotechnology Co. (Beijing, China). The annexin V-FITC&PI kit was from Jiamay Biotechnology 
(Beijing, China). Kinases inhibitors, including ERK1/2 inhibitor U0126, JNK inhibitor SP600125, p38 MAPK 
inhibitor SB202190, and protein degradation inhibitor MG132 were obtained from Cell Signaling Technology 
(Beverly, MA). PERK inhibitor GSK2606414 was from Selleck Chemicals (Houston, TX). Other reagents used in 
this study were ordered from Sigma, unless otherwise stated.
Cell culture and drug treatment. The IEC-6 cell is a non-transformed rat small intestinal epithelial cell 
line, whereas the IPEC-1 cell is a stable epithelial cell line prepared from the jejunum of the new born pig. The 
IPEC-1 cells were grown in DMEM-F12 medium supplemented with 10% FBS and 1% penicillin–streptomycin 
(Gibco, NY). The IEC-6 cells were obtained from ATCC and cultured in DMEM medium containing 10% FBS 
and 1% penicillin–streptomycin. Both cell lines were incubated at 37 °C in a humidified chamber with 5% CO2. 
For drug treatment, cells pretreated with 5 mM NAC for 2 h were incubated with 4-HNE. Thereafter, cells were 
harvested for analysis. In some experiments, cells were pretreated with kinase inhibitors and then were exposed 
to be treated with 4-HNE.
Cell viability assay. Cells seeded in 96-well plates at a density of 10,000 cells per well were treated as indi-
cated in figures, and cell viability was determined by the using of Cell counting kit (Zoman Biotech, Beijing) 
according to the protocol provided by the manufacturer. After the treatment, 10 μ L of CCK-8 was added to each 
well and then were incubated for 1 h. The optical density was determined at 450 nm using a Molecular Devices 
microplate reader.
Apoptotic cell death assay. Cells were treated as indicated and apoptotic cell death was determined by 
Hoechst 33342/PI staining and flow cytometric analysis. For Hoechst 33342/PI staining, cells were harvested and 
stained with Hoechst 33342 (5 μ g/mL) and propidium iodide (PI, 2.5 μ g/mL) for 10 min. Then the stained cells 
were observed under fluorescence microscope (Zeiss, Germany). The morphology was also examined and images 
were captured under a light microscope connected with a digital camera (Nikon, Japan). For Flow cytometry 
analysis, harvested cells were stained with annexin V-FITC and PI for 15 min at room temperature. Flow cytomet-
ric analysis was performed on a FACSCalibur flow cytometer (BD Biosciences), and data were analyzed using the 
CellQuest software. The percentage of apoptotic cells was calculated as the percentage of the number of apoptotic 
cells over the total number of the cells.
Determination of ROS production. The intracellular ROS production was determined by using 
DCFH-DA (2′ ,7′ dichlorofluorescein diacetate), an ROS-sensitive probe as previously described56. The DCFH-DA 
is a cell permeable indicator for ROS that is non-fluorescent until the acetate groups are removed and oxidation 
occurred in the cell and is irreversible converted into the fluorescent form DCF. For ROS measurements, cells 
were treated as indicated and DCFH-DA was introduced at a final concentration of 10 μ mol/L and incubated 
at 37 °C for another 20 min. The intracellular ROS level was determined by a fluorescence microscope (Zeiss 
Axiowert).
Measurements for reduced and oxidized glutathione. The reduced (GSH) and oxidized glutathione 
(GSSG) were determined by high-performance liquid chromatography (HPLC) as described57,58. In brief, cell 
samples were disrupted in homogenization buffer [12 mM iodoacetic acid:1.5 M HClO4 = 1:1(v/v)] by ultra-
sonic wave and centrifuged to deplete protein after 2 M K2CO3 was added. The S-carboxymethyl-glutathione, 
which forms a highly fluorescent derivative in the present of ortho-phthalaldehyde (OPA), was formed by 
using iodoacetic acid. The glutathione was analyzed by HPLC. HPLC separation was achieved in a C18 column 
(4.6 × 100 mm) with sodium acetate/methanol as solvents. Fluorescence at 480 nm was monitored after excitation 
at 394 nm.
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Quantitative real-time RT-PCR. Total RNA was extracted from cells using the Trizol reagent (CWBIO 
biotech Co., Beijing). Reverse transcription PCR was performed using the PrimeScript RT Reagent Kit (TaKaRa, 
Dalian, China), as instructed by the manufacturer and cDNA was used as template in the subsequent reactions. 
Real-time PCR was performed using SYBR Premix Ex Taq II (TaKaRa) and the ABI-Prism 7500 Sequence 
Detection System (Applied Biosystems) according to the instruction from the manufacturer. The primer sets used 
in this study were listed in supplementary Table S1. The mRNA level of β -actin was used as the internal control. 
The 2−ΔΔCT method was used to determine the fold changes in mRNA levels of each sample, as compared with 
the reference sample.
Immunoblot assays. Cells were harvested and lyszed on ice for 30 min in RIPA lysis buffer contain-
ing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 0.1% SDS, 1.0 mmol/L PMSF, 1.0 mmol/L Na3VO4, 
1.0 mmol/L NaF and protease inhibitor tablet (Roche, Indianapolis, IN), followed by sonication for 3 times with 
10 s/time. The whole-cell lysates were centrifuged at 12,000 rpm for 10 min to collect the supernatants. The protein 
extraction from cytoplasmic and nucleus fractions of cells was conducted by using a kit from Beyotime Institute 
of Biotechnology (Haimen, China) following the instruction. The protein concentration of the supernatant was 
determined using the Pierce BCA protein Assay Kit (Huaxingbio, Beijing) with bovine serum albumin as stand-
ard. Equal amounts of protein (25 μ g) were separated on SDS-page gels. Proteins were transferred to PVDF mem-
branes (Millipore, Billerica, MA). The membranes were blocked in 5% fat-free milk in TBST (Tris-buffered saline 
with Tween 20) for 1 hour at room temperature, and then were incubated with indicated primary antibodies over-
night at 4 °C. After incubation with horseradish peroxidase (HRP)-conjugated secondary antibody for 1 hour, the 
chemiluminescent signal was detected by using Super Enhanced Chemiluminescence Kit (Huaxingbio, Beijing).
Plasmids and transfection. To construct pcDNA-Mkp1, a DNA fragment containing the rat Mkp1 cod-
ing sequences was generated by PCR amplification and cloned into HindIII and EcoRI-restricted pcDNA 3.0 
(Invitrogen) as described59,60. All constructs were verified by DNA sequencing. Transient transfection of plasmids 
into HEK293 cells used FuGENE HD (Roch, Indianapolis, IN) transfection reagent according to the manufac-
turer’s instructions. After incubation for 24 h, the transfected cells were treated as indicated in figures for analy-
sis. To get stable expression, retroviral-mediated gene transfer was performed using pMN-GFP/IRES retrovirus 
vector-expressing MKP-1. Infected cells were sorted by GFP signals and expanded for in vitro studies.
Statistical analysis. Data were expressed as means ± SEM were statistically analyzed using one-way anal-
ysis of variance and Prism 5 for Windows (GraphPad Software, San Diego, CA). A value of p < 0.05 was taken to 
indicate statistically significant difference.
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